NEW YORK, Nov. 19 (GenomeWeb News) -  Genaissance Pharmaceuticals expects to pocket $6 million in a private placement of 3.55 million shares of newly issued common stock, and warrants for another 3.55 million shares to undisclosed institutional investors and other accredited investors, the firm said today.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

A genome-wide association study that linked common genetic variants to salivary gland carcinoma risk has been retracted, according to Retraction Watch.

Vampire bats' ability to live off blood is etched in their genomes and gut microbiomes, the Scientist reports.

In Genome Biology this week: peopling of the Sahara, epigenetic reprogramming analysis of liverwort, and more.